NO20011162L - Fremgangsmåter og preparater for modulering av interaksjonen mellom APJ-reseptoren og HIV-viruset - Google Patents

Fremgangsmåter og preparater for modulering av interaksjonen mellom APJ-reseptoren og HIV-viruset

Info

Publication number
NO20011162L
NO20011162L NO20011162A NO20011162A NO20011162L NO 20011162 L NO20011162 L NO 20011162L NO 20011162 A NO20011162 A NO 20011162A NO 20011162 A NO20011162 A NO 20011162A NO 20011162 L NO20011162 L NO 20011162L
Authority
NO
Norway
Prior art keywords
modulating
preparations
interaction
methods
hiv virus
Prior art date
Application number
NO20011162A
Other languages
English (en)
Other versions
NO20011162D0 (no
Inventor
Robert Doms
Daryl Faulds
Joseph E Hesselgesser
Richard Horuk
Branislava Mitrovic
Yiqing Zhou
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20011162L publication Critical patent/NO20011162L/no
Publication of NO20011162D0 publication Critical patent/NO20011162D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20011162A 1998-09-08 2001-03-07 FremgangsmÕter og preparater for modulering av interaksjonen mellom APJ-reseptoren og HIV-viruset NO20011162D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/149,045 US6475718B2 (en) 1998-09-08 1998-09-08 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus
PCT/EP1999/006553 WO2000014220A1 (en) 1998-09-08 1999-09-07 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus

Publications (2)

Publication Number Publication Date
NO20011162L true NO20011162L (no) 2001-03-07
NO20011162D0 NO20011162D0 (no) 2001-03-07

Family

ID=22528559

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011162A NO20011162D0 (no) 1998-09-08 2001-03-07 FremgangsmÕter og preparater for modulering av interaksjonen mellom APJ-reseptoren og HIV-viruset

Country Status (14)

Country Link
US (5) US6475718B2 (no)
EP (1) EP1109906A1 (no)
JP (1) JP2002532061A (no)
KR (1) KR20020013467A (no)
AU (1) AU767484B2 (no)
BR (1) BR9913635A (no)
CA (1) CA2341782A1 (no)
HU (1) HUP0103768A3 (no)
IL (1) IL141452A0 (no)
NO (1) NO20011162D0 (no)
PL (1) PL346564A1 (no)
RU (1) RU2225721C2 (no)
SK (1) SK3082001A3 (no)
WO (1) WO2000014220A1 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1419563A (zh) * 2000-03-23 2003-05-21 武田药品工业株式会社 肽衍生物
WO2001090123A2 (en) * 2000-05-23 2001-11-29 Genaissance Pharmaceuticals, Inc. Haplotypes of the agtrl1 gene
US20060045880A1 (en) * 2004-08-23 2006-03-02 Krieg Paul A Methods for modulating angiogenesis and apoptosis with apelin compositions
NO2708559T3 (no) 2008-04-11 2018-08-25
TWI440469B (zh) 2008-09-26 2014-06-11 Chugai Pharmaceutical Co Ltd Improved antibody molecules
AU2011337704B2 (en) 2010-11-30 2017-06-15 Chugai Seiyaku Kabushiki Kaisha Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
KR20200103845A (ko) 2011-02-25 2020-09-02 추가이 세이야쿠 가부시키가이샤 ＦｃγＲＩＩｂ 특이적 Ｆｃ 항체
EP2691530B1 (en) 2011-06-10 2018-03-07 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
EP3939996A1 (en) 2011-09-30 2022-01-19 Chugai Seiyaku Kabushiki Kaisha Antigen-binding molecule promoting disappearance of antigens having plurality of biological activities
TW201817744A (zh) 2011-09-30 2018-05-16 日商中外製藥股份有限公司 具有促進抗原清除之ＦｃＲｎ結合域的治療性抗原結合分子
WO2013090090A2 (en) * 2011-12-16 2013-06-20 Cargill, Incorporated Environmentally-friendly improved deicer compositions
WO2014152955A1 (en) 2013-03-14 2014-09-25 Regeneron Pharmaceuticals, Inc. Apelin fusion proteins and uses thereof
MX2016006709A (es) 2013-11-20 2016-09-08 Regeneron Pharma Moduladores de aplnr y usos de estos.
SI3233921T1 (sl) 2014-12-19 2022-01-31 Chugai Seiyaku Kabushiki Kaisha Protitelesa proti C5 in postopki za uporabo
CA2963760A1 (en) 2014-12-19 2016-06-23 Yoshinao Ruike Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use
SG10201907215QA (en) 2015-02-05 2019-09-27 Chugai Pharmaceutical Co Ltd Antibodies Comprising An Ion Concentration Dependent Antigen-Binding Domain, Fc Region Variants, Il-8-Binding Antibodies, And Uses Therof
PL3263132T3 (pl) 2015-02-27 2024-04-15 Chugai Seiyaku Kabushiki Kaisha Kompozycja do leczenia chorób związanych z il-6
WO2017110981A1 (en) 2015-12-25 2017-06-29 Chugai Seiyaku Kabushiki Kaisha Anti-myostatin antibodies and methods of use
CA3026050A1 (en) 2016-08-05 2018-02-08 Chugai Seiyaku Kabushiki Kaisha Composition for prophylaxis or treatment of il-8 related diseases
JP7191833B2 (ja) 2017-01-30 2022-12-19 中外製薬株式会社 抗スクレロスチン抗体およびその使用
US11851486B2 (en) 2017-05-02 2023-12-26 National Center Of Neurology And Psychiatry Method for predicting and evaluating therapeutic effect in diseases related to IL-6 and neutrophils

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0975749A2 (en) 1996-05-28 2000-02-02 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Cc chemokine receptor 5, antibodies thereto, transgenic animals
US6528625B1 (en) * 1996-10-28 2003-03-04 Millennium Pharmaceuticals, Inc. Anti-CCR5 antibodies and kits comprising same

Also Published As

Publication number Publication date
US20030008376A1 (en) 2003-01-09
US20030003447A1 (en) 2003-01-02
US20020062488A1 (en) 2002-05-23
SK3082001A3 (en) 2001-09-11
EP1109906A1 (en) 2001-06-27
AU767484B2 (en) 2003-11-13
US20030008279A1 (en) 2003-01-09
HUP0103768A3 (en) 2004-07-28
BR9913635A (pt) 2001-05-22
US6475718B2 (en) 2002-11-05
US20030008391A1 (en) 2003-01-09
CA2341782A1 (en) 2000-03-16
RU2225721C2 (ru) 2004-03-20
KR20020013467A (ko) 2002-02-20
PL346564A1 (en) 2002-02-11
HUP0103768A2 (hu) 2002-02-28
WO2000014220A1 (en) 2000-03-16
IL141452A0 (en) 2002-03-10
AU5973799A (en) 2000-03-27
JP2002532061A (ja) 2002-10-02
NO20011162D0 (no) 2001-03-07

Similar Documents

Publication Publication Date Title
NO20011162L (no) Fremgangsmåter og preparater for modulering av interaksjonen mellom APJ-reseptoren og HIV-viruset
NO20004104D0 (no) Preparater omfattende virus og fremgangsmÕter for konsentrering av viruspreparater
DE59711959D1 (de) Stabile lyophilisierte pharmazeutische zubereitungen von mono- oder polykonalen antikörpern
IS5245A (is) Lyfjablanda úr ómeprasól
FI943570A0 (fi) 1-bentseenisulfonyyli-1,3-dihydroindol-2-onijohdannaisia, niiden valmistus ja niitä sisältäviä lääkeaineita
ID28258A (id) Metode dan aparatus untuk balok seimbang memperkuat sesitifitas
IS5953A (is) Lyfjablöndur úr örgerðum eplerenonum
NO965539D0 (no) Farmasöytiske tacrinepreparater
NO20005839D0 (no) Preparater for behandling av HIV og andre virale infeksjoner
ID17499A (id) Alat suntik
DK1021547T3 (da) Vaccineformuleringer indeholdende papillomviruskapsomer og fremgangsmåder til anvendelse heraf
IS5943A (is) Aðferð og samsetningar til að endurheimta samræmdan stöðugleika próteina af p53 ættinni
DE69832657D1 (de) Empfangseinrichtungen und Empfangsverfahren
DE69835254D1 (de) Empfangseinrichtungen und Empfangsverfahren
NO20020571D0 (no) Peptider som blokkerer virusinfeksjonsevnen og fremgangsmåter for anvendelse av disse
ID28261A (id) Alat penghancur dan metoda penghancuran
ID19229A (id) Metode dan alat penginput huruf
DE69925820D1 (de) Zubereitungen zur stabilisierung von peg-interferon alpha konjugaten
ID22091A (id) Metoda dan aparatus untuk penyaringan bubur dari kertas bekas
DK0994706T3 (da) Præparater til oral indgivelse af taxaner og anvendelse deraf
NO983472D0 (no) Taxoider, deres fremstilling og farmas°ytiske preparater inneholdende taxoidene
IS5777A (is) Bóluefnisvakið lifrarbólgu B veiruafbrigði og notkun þess
NO20010464L (no) FremgangsmÕter og preparater for behandling av gastro- øsofagealt-reflukssyndrom
DE69738512D1 (de) Epstein-barr virus type b ctl epitopen
NO20004349D0 (no) Metoder og anordninger for modulering av immunresponsen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application